相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
Stephanie M. Williams et al.
BMC NEUROSCIENCE (2017)
Oligomeric alpha-synuclein and beta-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases
Stephanie M. Williams et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis
Kirsten L. Viola et al.
ACTA NEUROPATHOLOGICA (2015)
Biomarkers for Alzheimer's disease: a controversial topic
Giovanni B. Frisoni et al.
LANCET NEUROLOGY (2015)
Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study
Wai-Ying Wendy Yau et al.
LANCET NEUROLOGY (2015)
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Johannes Brettschneider et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Isolation and characterization of antibody fragments selective for toxic oligomeric tau
Huilai Tian et al.
NEUROBIOLOGY OF AGING (2015)
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
Thomas G. Beach et al.
NEUROPATHOLOGY (2015)
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology
Alison L. Baird et al.
FRONTIERS IN NEUROLOGY (2015)
A Sensitive Phage-Based Capture ELISA for Sub-Femtomolar Detection of Protein Variants Directly from Biological Samples
Stephanie Williams et al.
BIOTECHNOLOGY PROGRESS (2015)
TDP-43 is a key player in the clinical features associated with Alzheimer's disease
Keith A. Josephs et al.
ACTA NEUROPATHOLOGICA (2014)
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
Alan Rembach et al.
ALZHEIMERS & DEMENTIA (2014)
Immunotherapy for Alzheimer's disease
Thomas Wisniewski et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Christiane Reitz et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins
Marcos J. Guerrero-Munoz et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Tau-aggregation inhibitor therapy for Alzheimer's disease
Claude M. Wischik et al.
BIOCHEMICAL PHARMACOLOGY (2014)
A role for tau at the synapse in Alzheimer's disease pathogenesis
Amy M. Pooler et al.
NEUROPHARMACOLOGY (2014)
Novel plasma biomarker surrogating cerebral amyloid deposition
Naoki Kaneko et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2014)
Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients
Yu-Sheng Fang et al.
NATURE COMMUNICATIONS (2014)
Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer's Disease
Natalia Salvadores et al.
CELL REPORTS (2014)
Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer's Disease
Ming-Jang Chiu et al.
ACS CHEMICAL NEUROSCIENCE (2013)
The intersection of amyloid beta and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease
Johanna L. Crimins et al.
AGEING RESEARCH REVIEWS (2013)
New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF
Ting Yang et al.
ALZHEIMERS & DEMENTIA (2013)
Isolation and Characterization of Antibody Fragments Selective for Specific Protein Morphologies from Nanogram Antigen Samples
Srinath Kasturirangan et al.
BIOTECHNOLOGY PROGRESS (2013)
Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking
Joohyun Park et al.
NEUROBIOLOGY OF DISEASE (2013)
Increased Levels of Antigen-Bound β-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer's Disease Patients
Madalina Maftei et al.
PLOS ONE (2013)
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
Jon B. Toledo et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients
Michal J. Figurski et al.
ALZHEIMERS & DEMENTIA (2012)
Plasma amyloid-β oligomers level is a biomarker for Alzheimer's disease diagnosis
L. Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Tau oligomers and tau toxicity in neurodegenerative disease
Sarah M. Ward et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Nanobody specific for oligomeric beta-amyloid stabilizes nontoxic form
Srinath Kasturirangan et al.
NEUROBIOLOGY OF AGING (2012)
Neurochemical biomarkers in Alzheimer's disease and related disorders
Mirko Bibl et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Robert H. Baloh
FEBS JOURNAL (2011)
Inhibiting β-Secretase Activity in Alzheimer's Disease Cell Models with Single-Chain Antibodies Specifically Targeting APP
Shanta Boddapati et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease
Sergio T. Ferreira et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2011)
Identifying and validating biomarkers for Alzheimer's disease
Christian Humpel
TRENDS IN BIOTECHNOLOGY (2011)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aβ oligomers accumulation
Antonella Caccamo et al.
MOLECULAR NEURODEGENERATION (2010)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Characterisation of two antibodies to oligomeric Aβ and their use in ELISAs on human brain tissue homogenates
Zoe van Helmond et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
The Sun Health Research Institute Brain Donation Program: Description and experience, 1987-2007
Thomas G. Beach et al.
CELL AND TISSUE BANKING (2008)
Anti-oligomeric Aβ Single-chain Variable Domain Antibody Blocks Aβ-induced Toxicity Against Human Neuroblastoma Cells
Andleeb Zameer et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
Igor F. Tsigelny et al.
PLOS ONE (2008)
Intracellular amyloid-β in Alzheimer's disease
Frank M. LaFerla et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Temporal profile of amyloid-β (Aβ) oligomerization in an in vivo model of Alzheimer disease -: A link between Aβ and tau pathology
S Oddo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
分享论文
